Winston-Salem company to develop burn gel for radiation victims

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

WINSTON-SALEM, N.C. — A Winston-Salem biotechnology company has landed a $3.3 million federal contract that officials said will assist its development of a burn gel to treat radiation victims.

KeraNetics LLC was awarded the grant Monday by the Biomedical Advanced Research and Development Authority, an agency of the U.S. Department of Health and Human Services.

KeraNetics is a biomaterials company that is using keratin, which is found in hair, nails and skin, to develop therapeutic products.

Officials said it uses keratin in three areas: trauma applications for the healing of wounds, burns and resuscitation fluids; bone and nerve regeneration; and cell growth.

KeraNetics is developing a treatment for a cutaneous radiation injury called KeraStat Burn Gel.

“This project will complete vital portions of development work on a novel therapeutic that has been shown in initial studies to prevent cell and tissue damage after exposure to ionizing radiation,” said Dr. Luke Burnett, chief science officer for KeraNetics, according to The Winston-Salem Journal.

Read more: The Winston-Salem Journal.